Advanced search
Publication Cover
Nucleosides, Nucleotides & Nucleic Acids Volume 40, 2021 - Issue 3
Submit an article Journal homepage
370
Views
1
CrossRef citations to date
0
Altmetric
Articles

Highly efficient chemical phosphorylation of 6-(4-phenylpiperazine-1-yl)-9-(β-D-ribofuranosyl)-9H-purine

M. Fatih Polata Department of Pharmaceutical Basic Sciences, Faculty of Pharmacy, Erzincan Binali Yildirim University, Erzincan, TurkeyView further author information
&
Meral Tuncbilekb Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, Ankara, TurkeyCorrespondence[email protected]
View further author information
Pages 233-241 | Received 18 Aug 2020, Accepted 26 Oct 2020, Published online: 08 Jan 2021

References

  • G. M. Blackburn, M. J. Gait, D. Loakes, D. M. Williams, Eds., in Nucleic Acids Chem. Biol. Royal Society Of Chemistry, Cambridge, 2007, pp. i–iv.
  • Ferrero, M.; Gotor, V. Biocatalytic Selective Modifications of Conventional Nucleosides, Carbocyclic Nucleosides, and C-Nucleosides. Chem. Rev. 2000, 100, 4319–4347. DOI: 10.1021/cr000446y.
  • Seley-Radtke, K. L.; Yates, M. K. The Evolution of Nucleoside Analogue Antivirals: A Review for Chemists and Non-Chemists. Part 1: Early Structural Modifications to the Nucleoside Scaffold. Antiviral Res. 2018, 154, 66–86. DOI: 10.1016/j.antiviral.2018.04.004.
  • C. K. Chu, D. C. Baker, Eds., Nucleosides and Nucleotides as Antitumor and Antiviral Agents, Springer US, Boston, MA, 1993.
  • Thirumaran, R.; Prendergast, G. C.; Gilman, P. B. in Cancer Immunother. Elsevier, 2007, pp. 101–116.
  • Parker, W. B. Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of Cancer. Chem. Rev. 2009, 109, 2880–2893. DOI: 10.1021/cr900028p.
  • Cohen, M. H.; Johnson, J. R.; Justice, R.; Pazdur, R. FDA Drug Approval Summary: nelarabine (Arranon) for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma. Oncologist. 2008, 13, 709–714. DOI: 10.1634/theoncologist.2006-0017.
  • McLaughlin, P.; Robertson, L. E.; Keating, M. J. Cancer Treat. Res. 1996, 3–14.
  • Avendaño, C.; Menéndez, J. C. Medicinal Chemistry of Anticancer Drugs. Elsevier, 2008.
  • Sampath, D.; Rao, V. A.; Plunkett, W. Mechanisms of Apoptosis Induction by Nucleoside Analogs. Oncogene 2003, 22, 9063–9074. DOI: 10.1038/sj.onc.1207229.
  • Lamanna, N.; Weiss, M. Adv. Pharmacol. 2004, 107–125.
  • Luo, Z.; Jiang, Z.; Jiang, W.; Lin, D. C-H Amination of Purine Derivatives via Radical Oxidative Coupling. J. Org. Chem. 2018, 83, 3710–3718. DOI: 10.1021/acs.joc.8b00066.
  • Hocek, M.; Šilhár, P.; Shih, I.; Mabery, E.; Mackman, R. Cytostatic and Antiviral 6-Arylpurine Ribonucleosides. Part 7: Synthesis and Evaluation of 6-Substituted Purine l-Ribonucleosides. Bioorg. Med. Chem. Lett. 2006, 16, 5290–5293. DOI: 10.1016/j.bmcl.2006.07.092.
  • Senthilvelan, A.; Shanmugasundaram, M.; Kore, A. R. An Efficient Synthesis of 3'-O-Triazole Modified Guanosine-5'-O-Monophosphate Using Click Chemistry. Nucleosides Nucleotides Nucleic Acids 2019, 38, 418–427. DOI: 10.1080/15257770.2018.1554223.
  • Tuncbilek, M.; Bilget Guven, E.; Onder, T.; Atalay, R. C. Synthesis of Novel 6-(4-Substituted Piperazine-1-yl)-9-(β-D-Ribofuranosyl)Purine Derivatives, Which Lead to Senescence-Induced Cell Death in Liver Cancer Cells. J. Med. Chem. 2012, 55, 3058–3065. DOI: 10.1021/jm3001532.
  • Chen, X.; Kopecky, D. J.; Mihalic, J.; Jeffries, S.; Min, X.; Heath, J.; Deignan, J.; Lai, S.; Fu, Z.; Guimaraes, C.; et al. Structure-Guided Design, Synthesis, and Evaluation of Guanine-Derived Inhibitors of the eIF4E mRNA-Cap Interaction. J. Med. Chem. 2012, 55, 3837–3851., DOI: 10.1021/jm300037x.
  • Gillerman, I.; Fischer, B. An Improved One-Pot Synthesis of Nucleoside 5'-Triphosphate Analogues. Nucleosides Nucleotides Nucleic Acids 2010, 29, 245–256. DOI: 10.1080/15257771003709569.
  • Korboukh, I.; Hull-Ryde, E. A.; Rittiner, J. E.; Randhawa, A. S.; Coleman, J.; Fitzpatrick, B. J.; Setola, V.; Janzen, W. P.; Frye, S. V.; Zylka, M. J.; Jin, J. Orally Active Adenosine A(1) Receptor Agonists with Antinociceptive Effects in Mice. J. Med. Chem. 2012, 55, 6467–6477. DOI: 10.1021/jm3004834.
  • Lee Bennett, L.; Smithers, D.; Rose, L. M.; Adamson, D. J.; Brockman, R. W. Mode of Action of 2-Amino-6-Chloro-1-Deazapurine. Biochem. Pharmacol. 1984, 33, 261–271. DOI: 10.1016/0006-2952(84)90484-2.
  • Moreau, C.; Kirchberger, T.; Zhang, B.; Thomas, M. P.; Weber, K.; Guse, A. H.; Potter, B. V. L. Aberrant Cyclization Affords a C-6 Modified Cyclic Adenosine 5'-Diphosphoribose Analogue with Biological Activity in Jurkat T Cells. J. Med. Chem. 2012, 55, 1478–1489. DOI: 10.1021/jm201127y.
  • Swarbrick, J. M.; Graeff, R.; Zhang, H.; Thomas, M. P.; Hao, Q.; Potter, B. V. L. Cyclic Adenosine 5'-Diphosphate Ribose Analogs without a "Southern" Ribose Inhibit ADP-Ribosyl Cyclase-Hydrolase CD38. J. Med. Chem. 2014, 57, 8517–8529. DOI: 10.1021/jm501037u.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.